Literature DB >> 25172899

A near-infrared fluorescent voltage-sensitive dye allows for moderate-throughput electrophysiological analyses of human induced pluripotent stem cell-derived cardiomyocytes.

Angelica Lopez-Izquierdo1, Mark Warren1, Michael Riedel2, Scott Cho1, Shuping Lai2, Robert L Lux1, Kenneth W Spitzer1, Ivor J Benjamin2, Martin Tristani-Firouzi3, Chuanchau J Jou4.   

Abstract

Human induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM)-based assays are emerging as a promising tool for the in vitro preclinical screening of QT interval-prolonging side effects of drugs in development. A major impediment to the widespread use of human iPSC-CM assays is the low throughput of the currently available electrophysiological tools. To test the precision and applicability of the near-infrared fluorescent voltage-sensitive dye 1-(4-sulfanatobutyl)-4-{β[2-(di-n-butylamino)-6-naphthyl]butadienyl}quinolinium betaine (di-4-ANBDQBS) for moderate-throughput electrophysiological analyses, we compared simultaneous transmembrane voltage and optical action potential (AP) recordings in human iPSC-CM loaded with di-4-ANBDQBS. Optical AP recordings tracked transmembrane voltage with high precision, generating nearly identical values for AP duration (AP durations at 10%, 50%, and 90% repolarization). Human iPSC-CMs tolerated repeated laser exposure, with stable optical AP parameters recorded over a 30-min study period. Optical AP recordings appropriately tracked changes in repolarization induced by pharmacological manipulation. Finally, di-4-ANBDQBS allowed for moderate-throughput analyses, increasing throughput >10-fold over the traditional patch-clamp technique. We conclude that the voltage-sensitive dye di-4-ANBDQBS allows for high-precision optical AP measurements that markedly increase the throughput for electrophysiological characterization of human iPSC-CMs.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  QT prolongation; acquired long QT syndrome; optical action potential; preclinical drug screening; stem cell model

Mesh:

Substances:

Year:  2014        PMID: 25172899      PMCID: PMC4217013          DOI: 10.1152/ajpheart.00344.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  19 in total

1.  High-precision recording of the action potential in isolated cardiomyocytes using the near-infrared fluorescent dye di-4-ANBDQBS.

Authors:  Mark Warren; Kenneth W Spitzer; Bruce W Steadman; Tyler D Rees; Paul Venable; Tyson Taylor; Junko Shibayama; Ping Yan; Joseph P Wuskell; Leslie M Loew; Alexey V Zaitsev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-02       Impact factor: 4.733

2.  Reprogramming of human peripheral blood cells to induced pluripotent stem cells.

Authors:  Judith Staerk; Meelad M Dawlaty; Qing Gao; Dorothea Maetzel; Jacob Hanna; Cesar A Sommer; Gustavo Mostoslavsky; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2010-07-02       Impact factor: 24.633

3.  Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro.

Authors:  Daniela Malan; Stephanie Friedrichs; Bernd K Fleischmann; Philipp Sasse
Journal:  Circ Res       Date:  2011-07-28       Impact factor: 17.367

4.  Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals.

Authors:  Qiangzhe Zhang; Junjie Jiang; Pengcheng Han; Qi Yuan; Jing Zhang; Xiaoqian Zhang; Yanyan Xu; Henghua Cao; Qingzhang Meng; Li Chen; Tian Tian; Xin Wang; Pu Li; Jurgen Hescheler; Guangju Ji; Yue Ma
Journal:  Cell Res       Date:  2010-11-23       Impact factor: 25.617

5.  Modelling the long QT syndrome with induced pluripotent stem cells.

Authors:  Ilanit Itzhaki; Leonid Maizels; Irit Huber; Limor Zwi-Dantsis; Oren Caspi; Aaron Winterstern; Oren Feldman; Amira Gepstein; Gil Arbel; Haim Hammerman; Monther Boulos; Lior Gepstein
Journal:  Nature       Date:  2011-01-16       Impact factor: 49.962

6.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

Authors:  Alessandra Moretti; Milena Bellin; Andrea Welling; Christian Billy Jung; Jason T Lam; Lorenz Bott-Flügel; Tatjana Dorn; Alexander Goedel; Christian Höhnke; Franz Hofmann; Melchior Seyfarth; Daniel Sinnecker; Albert Schömig; Karl-Ludwig Laugwitz
Journal:  N Engl J Med       Date:  2010-07-21       Impact factor: 91.245

7.  Spectra, membrane binding, and potentiometric responses of new charge shift probes.

Authors:  E Fluhler; V G Burnham; L M Loew
Journal:  Biochemistry       Date:  1985-10-08       Impact factor: 3.162

8.  Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.

Authors:  Masayuki Yazawa; Brian Hsueh; Xiaolin Jia; Anca M Pasca; Jonathan A Bernstein; Joachim Hallmayer; Ricardo E Dolmetsch
Journal:  Nature       Date:  2011-02-09       Impact factor: 49.962

9.  Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.

Authors:  Elena Matsa; Divya Rajamohan; Emily Dick; Lorraine Young; Ian Mellor; Andrew Staniforth; Chris Denning
Journal:  Eur Heart J       Date:  2011-03-02       Impact factor: 29.983

10.  Functional and pharmacological analysis of cardiomyocytes differentiated from human peripheral blood mononuclear-derived pluripotent stem cells.

Authors:  Michael Riedel; Chuanchau J Jou; Shuping Lai; Robert L Lux; Alonso P Moreno; Kenneth W Spitzer; Elizabeth Christians; Martin Tristani-Firouzi; Ivor J Benjamin
Journal:  Stem Cell Reports       Date:  2014-05-29       Impact factor: 7.765

View more
  15 in total

Review 1.  High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.

Authors:  Juan C Del Álamo; Derek Lemons; Ricardo Serrano; Alex Savchenko; Fabio Cerignoli; Rolf Bodmer; Mark Mercola
Journal:  Biochim Biophys Acta       Date:  2016-03-04

Review 2.  Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research.

Authors:  Alexander Goedel; Ilaria My; Daniel Sinnecker; Alessandra Moretti
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

3.  Supervised Machine Learning for Classification of the Electrophysiological Effects of Chronotropic Drugs on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Christopher Heylman; Rupsa Datta; Agua Sobrino; Steven George; Enrico Gratton
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

4.  Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae.

Authors:  Ingra Mannhardt; Alexandra Eder; Berengere Dumotier; Maksymilian Prondzynski; Elisabeth Krämer; Martin Traebert; Klaus-Dieter Söhren; Frederik Flenner; Konstantina Stathopoulou; Marc D Lemoine; Lucie Carrier; Torsten Christ; Thomas Eschenhagen; Arne Hansen
Journal:  Toxicol Sci       Date:  2017-07-01       Impact factor: 4.849

Review 5.  Next-generation probes, particles, and proteins for neural interfacing.

Authors:  Jonathan Rivnay; Huiliang Wang; Lief Fenno; Karl Deisseroth; George G Malliaras
Journal:  Sci Adv       Date:  2017-06-09       Impact factor: 14.136

6.  Human Engineered Heart Tissue: Analysis of Contractile Force.

Authors:  Ingra Mannhardt; Kaja Breckwoldt; David Letuffe-Brenière; Sebastian Schaaf; Herbert Schulz; Christiane Neuber; Anika Benzin; Tessa Werner; Alexandra Eder; Thomas Schulze; Birgit Klampe; Torsten Christ; Marc N Hirt; Norbert Huebner; Alessandra Moretti; Thomas Eschenhagen; Arne Hansen
Journal:  Stem Cell Reports       Date:  2016-05-19       Impact factor: 7.765

7.  An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes.

Authors:  Wesley L McKeithan; Alex Savchenko; Michael S Yu; Fabio Cerignoli; Arne A N Bruyneel; Jeffery H Price; Alexandre R Colas; Evan W Miller; John R Cashman; Mark Mercola
Journal:  Front Physiol       Date:  2017-10-11       Impact factor: 4.566

Review 8.  Concise Review: Criteria for Chamber-Specific Categorization of Human Cardiac Myocytes Derived from Pluripotent Stem Cells.

Authors:  Christopher Kane; Cesare M N Terracciano
Journal:  Stem Cells       Date:  2017-06-27       Impact factor: 6.277

9.  Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.

Authors:  Chris Denning; Viola Borgdorff; James Crutchley; Karl S A Firth; Vinoj George; Spandan Kalra; Alexander Kondrashov; Minh Duc Hoang; Diogo Mosqueira; Asha Patel; Ljupcho Prodanov; Divya Rajamohan; William C Skarnes; James G W Smith; Lorraine E Young
Journal:  Biochim Biophys Acta       Date:  2015-10-31

10.  Di-4-ANEPPS Modulates Electrical Activity and Progress of Myocardial Ischemia in Rabbit Isolated Heart.

Authors:  Marina Ronzhina; Tibor Stracina; Lubica Lacinova; Katarina Ondacova; Michaela Pavlovicova; Lucie Marsanova; Radovan Smisek; Oto Janousek; Katerina Fialova; Jana Kolarova; Marie Novakova; Ivo Provaznik
Journal:  Front Physiol       Date:  2021-06-10       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.